Nectar Lifesciences Cash Flow Annual

BSE: - | NSE: - | ISIN: - | Sector: -
12.51 -0.38 (-2.95%)Updated : 14 May 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Issuance( Retirement)of Debt Net -53.51-118.29-106.10-39.54
Net Changein Cash -0.582.23-0.23-7.73
Cash Taxes Paid 0.000.000.000.00
Net Income/ Starting Line -161.5318.27-42.4234.08
Changesin Working Capital 191.9568.8777.93-64.54
Cashfrom Operating Activities 169.44224.69133.6595.01
Cash Interest Paid 74.5887.1479.4978.81
Cashfrom Financing Activities -128.09-205.44-185.58-119.38
Depreciation/ Depletion 62.3960.7259.1256.97
Other Investing Cash Flow Items Total 1.8612.3981.7641.61
Capital Expenditures -43.80-29.42-30.06-24.97
period Type ----
Non- Cash Items 76.6376.8339.0368.50
Financing Cash Flow Items -74.58-87.14-79.49-78.81
period Length 12.0012.0012.0012.00
Cashfrom Investing Activities -41.93-17.0351.7016.64
Total Cash Dividends Paid ----1.03
*All figures in crores except per share values
Recommended For You
Trending Stocks
4,513.40+204.90(4.76%)
2,600.00+70.55(2.79%)
1,019.55-72.25 (-6.62%)
954.60-17.95 (-1.85%)